DiaMedica Therapeutics Inc. (DMAC) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for DiaMedica Therapeutics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -11.41x | -8.98x | -4.77x | -3.05x | -5.70x | -12.94x |
| P/B Ratio | 6.66x | 5.39x | 1.81x | 1.31x | 1.76x | 6.11x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 11.81x | 8.28x | 19.27x | 15.61x | 29.82x | 13.77x |
| Quick Ratio | 11.81x | 8.28x | 19.27x | 15.61x | 29.82x | 13.77x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..